single invest

Antag Therapeutics

Antag Therapeutics is retargeting metabolic diseases and is working with therapeutic peptides for the treatment of dietary-related metabolic diseases.

Antag Therapeutics has been a part of the Accelerace accelerator program, that help startup companies accelerate and scale up their business model and finetune their companies. Antag Therapeutics is one of more than 500 companies that Accelerace already have accelerated.

Related startups